906 related articles for article (PubMed ID: 15085592)
1. [Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP)].
Czakó L; Takács T; Morvay Z; Csernay L; Lonovics J
Orv Hetil; 2004 Mar; 145(10):529-34. PubMed ID: 15085592
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP.
Czakó L; Takács T; Morvay Z; Csernay L; Lonovics J
World J Gastroenterol; 2004 Oct; 10(20):3034-8. PubMed ID: 15378788
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases.
Lomanto D; Pavone P; Laghi A; Panebianco V; Mazzocchi P; Fiocca F; Lezoche E; Passariello R; Speranza V
Am J Surg; 1997 Jul; 174(1):33-8. PubMed ID: 9240949
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of MRCP compared to ERCP in the diagnosis of biliary and pancreatic duct].
Hatano S; Kondoh S; Akiyama T; Okita K
Nihon Rinsho; 1998 Nov; 56(11):2874-9. PubMed ID: 9847613
[TBL] [Abstract][Full Text] [Related]
5. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis.
Sherman S; Freeman ML; Tarnasky PR; Wilcox CM; Kulkarni A; Aisen AM; Jacoby D; Kozarek RA
Gastroenterology; 2014 Sep; 147(3):646-654.e2. PubMed ID: 24906040
[TBL] [Abstract][Full Text] [Related]
6. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
[TBL] [Abstract][Full Text] [Related]
7. Value of magnetic-resonance cholangio-pancreatography (MRCP) after unsuccessful endoscopic-retrograde cholangio-pancreatography (ERCP).
Adamek HE; Weitz M; Breer H; Jakobs R; Schilling D; Riemann JF
Endoscopy; 1997 Oct; 29(8):741-4. PubMed ID: 9427493
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology.
Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA
Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP).
Hintze RE; Adler A; Veltzke W; Abou-Rebyeh H; Hammerstingl R; Vogl T; Felix R
Endoscopy; 1997 Mar; 29(3):182-7. PubMed ID: 9201467
[TBL] [Abstract][Full Text] [Related]
10. The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease.
Sahai AV; Devonshire D; Yeoh KG; Kay C; Feldman D; Willner I; Farber J; Patel R; Tamasky PR; Cunningham JT; Trus T; Hawes RH; Cotton PB
Am J Gastroenterol; 2001 Jul; 96(7):2074-80. PubMed ID: 11467634
[TBL] [Abstract][Full Text] [Related]
11. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
[TBL] [Abstract][Full Text] [Related]
12. Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects.
Fulcher AS; Turner MA; Capps GW; Zfass AM; Baker KM
Radiology; 1998 Apr; 207(1):21-32. PubMed ID: 9530295
[TBL] [Abstract][Full Text] [Related]
13. Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis.
Scheiman JM; Carlos RC; Barnett JL; Elta GH; Nostrant TT; Chey WD; Francis IR; Nandi PS
Am J Gastroenterol; 2001 Oct; 96(10):2900-4. PubMed ID: 11693324
[TBL] [Abstract][Full Text] [Related]
14. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique.
Vitellas KM; Keogan MT; Spritzer CE; Nelson RC
Radiographics; 2000; 20(4):939-57; quiz 1107-8, 1112. PubMed ID: 10903685
[TBL] [Abstract][Full Text] [Related]
15. Application of endoscopic retrograde cholangiopancreatography in biliary-pancreatic diseases.
Huang LY; Liu YX; Wu CR; Cui J; Zhang B
Chin Med J (Engl); 2009 Dec; 122(24):2967-72. PubMed ID: 20137483
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance cholangiopancreatography. A new method of noninvasive biliopancreatic diagnosis].
Pavone P; Laghi A; Catalano C; Broglia L; Scipioni A; Di Girolamo M; Sarrantonio A; Passariello R
Radiol Med; 1995 Oct; 90(4):438-43. PubMed ID: 8552821
[TBL] [Abstract][Full Text] [Related]
17. [MR cholangiopancreatography: technique, indications and clinical results].
Pavone P; Laghi A; Panebianco V; Catalano C; Passariello R
Radiol Med; 1997 Dec; 94(6):632-41. PubMed ID: 9524602
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance cholangiopancreatography (MRCP) versus endoscopic retrograde cholangiopancreatography (ERCP): diagnostic usefulness].
Pamos S; Rivera P; Canelles P; Quiles F; Ortí E; Cuquerella J; Martínez V; Medina E
Gastroenterol Hepatol; 1998 Apr; 21(4):174-80. PubMed ID: 9633177
[TBL] [Abstract][Full Text] [Related]
19. [The usefulness of MRCP in the initial diagnosis of the biliary and pancreatic diseases compared with ERCP].
Iwano M; Mukai H; Mizuma Y; Takino T; Ashihara T; Ueda T; Matumura S; Fujita T; Takano Y; Fujiwara H; Watanabe A; Masuzawa A
Nihon Rinsho; 1998 Nov; 56(11):2880-4. PubMed ID: 9847614
[TBL] [Abstract][Full Text] [Related]
20. MR cholangiopancreatography after unsuccessful or incomplete ERCP.
Soto JA; Yucel EK; Barish MA; Chuttani R; Ferrucci JT
Radiology; 1996 Apr; 199(1):91-8. PubMed ID: 8633178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
